SCHEMBL4848072

SCHEMBL4848072

COc1ccc(C(=O)C=Cc2cc(-c3ccccc3OC)ccc2OCCN(C)C)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
MEN1 O00255 2/20 0.48
HPGD P15428 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 2/20 0.48
ALDH1A1 P00352 2/20 0.48
ALOX12 P18054 1/20 0.48
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
TNFRSF1A P19438 1/20 0.45
HTR7 P34969 1/20 0.44
RELA Q04206 1/20 0.44
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4848487 0.92 LMNA (0.46) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4848052 0.91 ABCG2 (0.48) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4851264 0.90 MAPT (0.45) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4848064 0.90 MAPT (0.45) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4854497 0.90 MEN1 (0.48) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4854790 0.90 ABCG2 (0.50) LMNAMEN1KMT2AALDH1A1PDE4A
SCHEMBL4846183 0.88 LMNA (0.45) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4849956 0.88 LMNA (0.53) LMNAMEN1HPGDKMT2AGAA
SCHEMBL4846089 0.86 MAOB (0.55) LMNAALDH1A1TNFRSF1AHTR7RELA
SCHEMBL4846635 0.86 LMNA (0.48) LMNAMEN1HPGDKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed